Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT01201356
Status:
COMPLETED
Last Update Posted:
2021-04-21
First Post:
2010-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-10
First Submit QC Date:
None
Study First Post Date:
2010-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-15
Results First Submit QC Date:
None
Results First Post Date:
2019-11-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-26
Last Update Post Date:
2021-04-21
Last Update Post Date Type:
ACTUAL